Paricalcitol

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
ANDA207692 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Paricalcitol Injection, Usp Is Indicated For The Prevention And Treatment Of Secondary Hyperparathyroidism Associated With Chronic Kidney Disease Stage 5.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Paricalcitol PARICALCITOL ZINC13911941

Comments